- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Protein Kinetics in South Africa
Total 395 results
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Italy, Poland, Spain, Taiwan, Brazil, Greece, Ireland, Mexico, Canada, Korea, Republic of, Germany, France, Australia, United Kingdom, Argentina, India, Thailand, Switzerland
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands
-
Bioverativ, a Sanofi companySwedish Orphan BiovitrumCompletedHemophilia BUnited States, Italy, Ireland, New Zealand, United Kingdom, Australia, Netherlands, Denmark, Poland, Sweden, France
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, Australia, Czechia, Korea, Republic of, Taiwan, Poland, Bulgaria, United Kingdom, Germany, Turkey, Israel, Malaysia, Ukraine, Russian Federation, Austria, Switzerland, Japan, Hong Kong, Lithuania, Roman... and more
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingDS Stage I Multiple Myeloma | DS Stage II Multiple Myeloma | DS Stage III Multiple MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
Janssen Scientific Affairs, LLCTerminated
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Puerto Rico
-
Janssen Research & Development, LLCCompletedMultiple MyelomaIsrael, Czechia, United States, Germany, Spain, United Kingdom, France, Japan, Brazil
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Greece, Korea, Republic of, Singapore
-
CelgeneActive, not recruiting
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Puerto Rico
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Belgium, Korea, Republic of, United Kingdom, Sweden, Italy, Denmark, Japan, Taiwan, China, Germany, Spain, France, Netherlands, Turkey, Russian Federation, Poland, Greece, Argentina, Brazil
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Canada, Spain, Belgium, United Kingdom, Australia, Japan, France, Germany, Poland
-
Novo Nordisk A/SCompletedHaemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia BFrance, United States, India, Mexico, United Kingdom, Netherlands, Sweden, Korea, Republic of, Spain, Switzerland, Serbia, Turkey, Bulgaria, Italy, Japan, Poland, South Africa, Croatia, Algeria, Australia, Bosnia and Herzegovina, ... and more
-
Hoffmann-La RocheCompletedHemophilia ACanada, Australia, Belgium, India, Germany, Israel, Italy, Spain, Colombia, United Kingdom, Netherlands, Saudi Arabia, Hungary, Guatemala, Russian Federation, Poland, Switzerland, Finland, Panama, Brazil, Mexico, Portugal, Romania, Sw...
-
SanofiActive, not recruitingPlasma Cell MyelomaMexico, Sweden, Poland, France, Czechia, Greece, Taiwan, Lithuania, Portugal, Spain, Australia, Italy, New Zealand, Russian Federation, Turkey, Japan, United States, Belgium, China, Denmark, Germany
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Lymphoproliferative DisorderUnited States
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Italy, Spain, France, Canada
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingVon Willebrand DiseaseUnited States, Belgium, Spain, Italy, Turkey, Germany, Austria, France, Czechia, Russian Federation, Ukraine, United Kingdom, Netherlands
-
Société des Produits Nestlé (SPN)CompletedShort Bowel Syndrome | Cow's Milk Protein Allergy | Eosinophilic Gastrointestinal Disorders | Malabsorption/Maldigestion | Multiple Food AllergiesUnited States
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedHemophilia ACzechia, Switzerland, Denmark, Canada, Australia, Austria, France, United Kingdom, Italy, Sweden, Belgium, Brazil, China, Colombia, Greece, Hungary, Norway, Poland, Portugal, Russian Federation, Slovenia, Spain
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AFrance, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, Japan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Puerto Rico, Norway, Korea, Republic of, Bulgaria, Russian...
-
Nkarta Inc.RecruitingLymphoma, Non-Hodgkin | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | B-cell Acute Lymphoblastic Leukemia | Small Lymphocytic Lymphoma | Large B-cell Lymphoma | Indolent Lymphoma | Aggressive Lymphoma | Large-cell LymphomaUnited States, Australia
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMultiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Canada, Spain, Israel, United Kingdom, Germany, Austria, Belgium, France, Italy, Ireland, Netherlands, Sweden
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseNetherlands, Spain, United States, Belgium, Australia, United Kingdom, Austria, Italy, Bulgaria, Japan, Poland, Germany, India, Canada, Russian Federation, Sweden
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, Australia, Poland, Ukraine, Germany, Spain, Turkey, Korea, Republic of, Brazil, Russian Federation, Netherlands, Hungary, Sweden, Czechia, Mexico
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
Janssen Research & Development, LLCApproved for marketingMultiple MyelomaUnited States, United Kingdom, Spain, Brazil, Russian Federation, Japan
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
TakedaCompletedMultiple MyelomaFrance, Spain, United States, Taiwan, Korea, Republic of, Israel, Australia, Czechia, Hungary, Canada, Japan, Portugal, Singapore, United Kingdom, Italy, Sweden, Poland, Germany, China, Denmark, Greece, Thailand, Serbia, Turkey, Colombia, Russian Federation and more
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Italy, Israel, Portugal, Germany, Turkey, Greece, Ireland, Austria, Norway, Netherlands, Denmark, Poland, France, Russian Federation, Canada, Finland, Japan, Puerto Rico, Sweden
-
PfizerCompletedAdvanced Multiple MyelomaGermany, United States, Spain, United Kingdom, Belgium, Canada, France, Greece
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia AUnited States, Netherlands, Spain, Switzerland, Taiwan, Turkey, United Kingdom, Croatia, Germany, Brazil, France, Japan, Australia, Hungary, Israel, Korea, Republic of, Lithuania, Portugal, Ukraine, Greece, Italy, Denmark, Norway, Canada and more
-
PharmaMarCompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Austria, Belgium, Czechia, France, Germany, Greece, Ireland, Italy, Korea, Republic of, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Spain, Taiwan, United Kingdom
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia